Thinking of joining a study?

Register your interest

NCT05873660 | COMPLETED | Obesity


A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
Sponsor:

Novo Nordisk A/S

Brief Summary:

The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.

Condition or disease

Obesity

Overweight

Intervention/treatment

No treatment given

Study Type : OBSERVATIONAL
Estimated Enrollment : 5360 participants
Official Title : Multi-centre Cross-sectional Observational Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
Actual Study Start Date : 2023-06-12
Estimated Primary Completion Date : 2024-06-24
Estimated Study Completion Date : 2024-06-24

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Criteria
Inclusion Criteria
  • 1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • 2. Adults, age above or equal to 18 years at the time of signing informed consent.
  • 3. Have established CVD and equal to or greater than 1 follow up appointment following an acute event from at least one of the following
    • * Prior myocardial infarction
    • * Prior stroke (ischemic or haemorrhagic stroke)
    • * Symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease
    Exclusion Criteria
    • 1. Previous participation in this study. Participation is defined as having given informed consent in this study
    • 2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
    • 3. Patients with known congenital heart disease/malformation

A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease

Location Details

NCT05873660


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, New Jersey

Novo Nordisk Investigational Site

Plainsboro, New Jersey, United States, 08536

Not yet recruiting

Brazil,

Novo Nordisk Investigational Site

São Paulo, Brazil,

Not yet recruiting

Canada,

Novo Nordisk Investigational Site

Ontario, Canada,

Not yet recruiting

Saudi Arabia,

Novo Nordisk Investigational Site

Riyadh, Saudi Arabia,

Not yet recruiting

Spain,

Novo Nordisk Investigational Site

Madrid, Spain,

Loading...